These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 17362500)
1. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500 [TBL] [Abstract][Full Text] [Related]
2. Oxidative status and serum PON1 activity in beta-thalassemia minor. Selek S; Aslan M; Horoz M; Gur M; Erel O Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173 [TBL] [Abstract][Full Text] [Related]
3. Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810 [TBL] [Abstract][Full Text] [Related]
4. Serum paraoxonase activity in uremic predialysis and hemodialysis patients. Dirican M; Akca R; Sarandol E; Dilek K J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056 [TBL] [Abstract][Full Text] [Related]
5. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation. Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476 [TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. Camuzcuoglu H; Arioz DT; Toy H; Kurt S; Celik H; Erel O Gynecol Oncol; 2009 Mar; 112(3):481-5. PubMed ID: 19101714 [TBL] [Abstract][Full Text] [Related]
7. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients. Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454 [TBL] [Abstract][Full Text] [Related]
8. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus. Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735 [TBL] [Abstract][Full Text] [Related]
9. Paraoxonase and arylesterase activities in coronary artery disease. Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345 [TBL] [Abstract][Full Text] [Related]
11. Determination of oxygen derived free radicals producer (xanthine oxidase) and scavenger (paraoxonase1) enzymes and lipid parameters in different cancer patients. Samra ZQ; Pervaiz S; Shaheen S; Dar N; Athar MA Clin Lab; 2011; 57(9-10):741-7. PubMed ID: 22029190 [TBL] [Abstract][Full Text] [Related]
12. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks. Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515 [TBL] [Abstract][Full Text] [Related]
13. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals. Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106 [TBL] [Abstract][Full Text] [Related]
14. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. Rosenblat M; Karry R; Aviram M Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851 [TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis. Kannampuzha J; Darling PB; Maguire GF; Donnelly S; McFarlane P; Chan CT; Connelly PW Clin Nephrol; 2010 Feb; 73(2):131-8. PubMed ID: 20129020 [TBL] [Abstract][Full Text] [Related]
16. [Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease]. Gamboa R; Regalado JC; Huesca-Gómez C; Posadas-Romero C; Verdejo Paris J; Vargas-Alarcón G; Pérez-Méndez O Arch Cardiol Mex; 2008; 78(4):360-8. PubMed ID: 19205543 [TBL] [Abstract][Full Text] [Related]
17. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women. Kumru S; Aydin S; Gursu MF; Ozcan Z Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):177-81. PubMed ID: 15140512 [TBL] [Abstract][Full Text] [Related]
18. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886 [TBL] [Abstract][Full Text] [Related]